USPTO serial 77113149
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Amy E. Schmid
Ray Thomas, Jr. Wenderoth, Lind & Ponack, L.L.P.1030 15th Street N.W.Suite 400 EastWashington, DC 20005| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, veterinary preparations for liver diseases, renal disease, nerve system diseases, skin diseases, cardiovascular diseases, cancer and sanitary preparations for medical use; central nervous system stimulants; hair growth stimulant; antipyretic analgesics; anti-epileptics; analeptics; hypnotic sedatives; general anesthetics; anti-motion sickness preparations; pharmaceutical preparations acting on the peripheral nervous system; local anesthetics; skeletal muscle relaxants; anhidrotics; autonomics; antispasmodics; diaphoretics; pharmaceutical preparations acting on the sensory organs; ophthalmic preparations; agents for otic and nasal use, namely, nasal spray preparations, eye washes, eye drops, irrigating solutions for eye use; treatment for eye infection, macular degeneration, retinopathy, rhinitis, sinusitis; pharmaceutical antiallergic preparations; antihistaminics; cardiovascular treatment preparations; cardiotonics; antihypertensives; vasoconstrictors; capillary stabilizers; cerebral hemorrhage prophylactic preparations; antiarrhythmic preparations; diuretics; pharmaceutical preparations acting on respiratory organs; respiratory stimulants; anti-cough drops; antitussive expectorants; pharmaceutical preparations acting on digestive organs; gastrointestinal cleaning agents; clysters; evacuants (purgatives); stomachics and digestives; pharmaceutical preparations for oral use, for oral inflammation; emetics; pharmaceutical preparations for dental purposes for gingivostomatitis, alveolar abscess, alveoloclasia; antacids; antiemetics; castor oil for medical purposes; cholagogues; hormones for medical purposes; thyroid and para-thyroid hormone preparations; mixed hormone preparations; estrogen preparations; pancreas hormone preparations; salivary gland hormone preparations; androgen preparations; pituitary hormone preparations; adrenal hormone preparations; pharmaceutical preparations acting on uro-genital and anal organs; oxytocics; anti-hemorrhoidals; emmenagogues; contraceptives; medicated skin care preparations; pharmaceutical preparations for purulence; anti-dermoinfectives; antimicrobials for dermatologic use; astringents; anti-inflammatory agents; analgesics; anti-itchings; talcum powder; medicated baby oils; medicated baby powders; medicated bath preparations; vitamin preparations; cod-liver oil drops; mixed vitamin preparations; vitamin A preparations; vitamin C preparations; vitamin D preparations; vitamin B preparations; multi-vitamin preparations; amino acid preparations for medical purposes; threonine preparations; tryptophane preparations; methionine preparations; lysine preparations; royal jelly for medical purposes; calcium supplements; chondroitin preparations; protein and amino acid preparations for medical purposes; saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dematitis, erythroderma, keratosis, dyschromatosis, lupus erhthematosus; mineral preparations for medical use; anticoagulants; blood substitutes for human and veterinary use; blood plasma; hemostatics; pharmaceutical preparations affecting metabolism; antidotes; enzyme preparations for medical purposes; lactagogues; lipotropic factor preparations; pharmaceutical preparations for the treatment of habitual intoxication; pharmaceutical preparations for activating cellular function; tumor suppressing agents; anti-cancer preparations; anti-sarcoma preparations; pharmaceutical preparations for treating physically caused lesions; pharmaceutical preparations for treating heatstroke; radiation sickness treating drugs; pharmaceutical preparations for treating chemically caused disorders, namely, chemical burn, side effect of anticancer drugs, immunosuppresants; chlorine-detoxication preparations; arsenic-detoxication preparations; benzol-detoxication preparations; antibiotic preparations; erythromycin preparations; chloramphenicol preparations; colistin-polymixin preparations; salkomycin preparations; streptomycin preparations; thiolutin preparations; tetracycline preparations; trichomycin preparations; mixed antibiotic preparations; penicillin preparations; chemotherapeutics; antisyphilitics; antituberculous preparations; sulfonamide preparations; antileprotic preparations; biological preparations for medical purposes; antitoxic sera; antitoxins; mixed biological preparations for medical purposes; preparations for biological tests for medical purposes; toxoids; vaccines; preparations for destroying parasites; anthelmintics; odor neutralizing preparations for use on drugs; pharmaceutical excipients; diagnostic preparations for medical use; X-ray contrast agents; diagnostic reagents for medical use; diagnostic media for bacteriological cultures for medical use; radio isotope markers for therapeutic or diagnostic use; opium alkaloid preparations; synthetic narcotics; coca alkaloid preparations; mosquito-repellent incenses; germicides and fungicides; rodenticides; insecticides; fumigants; herbicides, namely, weedkillers; insect-repellents; antiseptics | SECTION 8 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 21, 2014 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 13, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 17, 2007 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Jun 13, 2007 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Jun 12, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 12, 2007 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Jun 12, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 12, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 9, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| May 3, 2007 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| May 3, 2007 | ALIE | ASSIGNED TO LIE | — |
| Apr 5, 2007 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 27, 2007 | NWAP | NEW APPLICATION ENTERED | — |